Work

EP.11.19 Efficacy and Safety of Continuing Tislelizumab After Progression of First-Line Tislelizumab in Patients With Advanced NSCLC

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.1526

Authors: B. Qin, X. Ge, J. Zhai, Y. Mao, S. Sheng, Y. Jia, Y. Gao, Y. Li, L. Lin, M. Li, H. Zhou, J. Wang

Institutions: Chinese PLA General Hospital, Nankai University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415520470

FWCI:

Cites:

Cited by:

Related to: 10